Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis
Authors:
Open Access
- 17 August 2006
- journal article
- Published by Wiley in American Journal of Hematology
- Vol. 82 (2) , 174
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- ACUTE SPLENIC SEQUESTRATION IN JAMAICAN ADULTS WITH HOMOZYGOUS SICKLE CELL DISEASE: A ROLE OF ALPHA THALASSAEMIABritish Journal of Haematology, 2008
- Heparin-induced thrombocytopenia: clinical manifestations and management strategiesThe American Journal of Medicine, 2005
- Evolving Management Strategies for Heparin-Induced ThrombocytopeniaSeminars in Hematology, 2005
- Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosisJournal of Thrombosis and Haemostasis, 2005
- The Role of VEGF in Oncology: Effects on Hemostasis and ThrombosisPathophysiology of Haemostasis and Thrombosis, 2003
- Genetic risk factors of venous thrombosisHuman Genetics, 2001
- A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma LevelsJournal of Vascular Research, 2000
- Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor geneHuman Immunology, 1999
- Acute splenic sequestration crisis in a young woman with homozygous sickle cell anaemiaPostgraduate Medical Journal, 1989
- Fatal splenic sequestration in adult sickle cell diseaseClinical and Laboratory Haematology, 1988